Literature DB >> 22039911

Two novel frameshift mutations of the DSRAD gene in Chinese pedigrees with dyschromatosis symmetrica hereditaria.

Yan Liu1, Feng Liu, Xiaopeng Wang, Jia Huo, Qingqiang Xu, Xiaoli Li, Jianwen Ren, Mei Wang, Shengxiang Xiao, Zhenhui Peng.   

Abstract

BACKGROUND: Dyschromatosis symmetrica hereditaria (DSH) is an autosomal dominant disorder characterized by a mixture of hyperpigmented and hypopigmented macules localized on the back of the extremities and caused by the mutations in the DSRAD gene.
METHODS: Two Chinese pedigrees of typical DSH were subjected to mutation detection in DSRAD. Direct sequencing of all PCR products of the whole coding regions of DSRAD was performed to identify the mutation.
RESULTS: The c.1615delG (p.V539fs) mutation was found in the affected members but not in the healthy individuals in family 1 and the c.ins1372-9 CCACAGAT (p.D458fs) mutation was found in patients but not in the healthy members of family 2.
CONCLUSION: Our study found two novel frameshift mutations in the DSRAD gene. We add new variants to the knowledge of DSRAD mutations in DSH.
© 2012 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039911     DOI: 10.1111/j.1365-4632.2011.05209.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  2 in total

1.  Dyschromatosis symmetrica hereditaria of late onset?

Authors:  Caroline Balvedi Gaiewski; Sergio Zuneda Serafini; Betina Werner; Janyana M D Deonizio
Journal:  Case Rep Dermatol Med       Date:  2014-02-04

2.  A novel P53/POMC/Gαs/SASH1 autoregulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentation.

Authors:  Ding'an Zhou; Zhiyun Wei; Zhongshu Kuang; Huangchao Luo; Jiangshu Ma; Xing Zeng; Ke Wang; Beizhong Liu; Fang Gong; Jing Wang; Shanchuan Lei; Dongsheng Wang; Jiawei Zeng; Teng Wang; Yong He; Yongqiang Yuan; Hongying Dai; Lin He; Qinghe Xing
Journal:  J Cell Mol Med       Date:  2016-11-25       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.